All stock lists
Atlantic American Corporation (NASDAQ:AAME)
US · Delayed Price · Currency is USD
Financial Services · Insurance - Life
$1.26-$0.01 (-0.79%)
Market cap
$25.7M
Insider Score
Health Score
Listed since
Mar 17, 1980
Website
Insider Score
––Not scored
AAME Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From AAME’s reported statements · Q4 2025 (trailing 12 months)
Profitability11 / 20
Profitable, but on a thin margin.
- Revenue
- $210.4M
- Net income
- $6.0M
- Net margin
- 2.9%
Leverage20 / 20
Little or no net debt.
- Total debt
- $38.8M
- Cash
- $43.6M
- Net debt / EBITDA
- -0.43x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $395.0M
- Current liabilities
- $187.1M
- Current ratio
- 2.11
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $32.9M
- Free cash flow
- $32.4M
- FCF margin
- 15.4%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 20.4M
- Share growth (1y)
- -0.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
AAME Income Statement
| Fiscal Period | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
| Revenue | $51.27 M | $53.76 M | $55.29 M | $50.13 M | $49.04 M | $44.52 M |
| Revenue Growth (YoY) | 4.53 % | 20.76 % | 15.99 % | 6.66 % | 4.92 % | -0.16 % |
| Cost of Revenue | $31.28 M | $35.12 M | $46.52 M | $43.59 M | $43.63 M | $42.25 M |
| Gross Profit | $19.98 M | $18.64 M | $8.77 M | $6.53 M | $5.41 M | $2.27 M |
| SG&A Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $18.28 M | $17.87 M | $4.56 M | $5.50 M | $4.87 M | $4.72 M |
| Operating Income | $1.70 M | $769.00 K | $4.22 M | $1.03 M | $545.00 K | -$2.45 M |
| Pretax Income | $1.70 M | $769.00 K | $4.22 M | $1.03 M | $545.00 K | -$2.45 M |
| Tax Provision | $379.00 K | $192.00 K | $900.00 K | $233.00 K | $133.00 K | -$456.00 K |
| Net Income | $1.32 M | $577.00 K | $3.32 M | $802.00 K | $412.00 K | -$2.00 M |
| EPS (Basic) | $0.06 | $0.03 | $0.16 | $0.03 | $0.02 | -$0.10 |
| EPS (Diluted) | $0.06 | $0.03 | $0.15 | $0.03 | $0.02 | -$0.10 |
| Shares Outstanding | 20.40 M | 20.40 M | 20.40 M | 20.40 M | 20.40 M | 19.43 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
